UBS AM’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $803K | Buy |
106,580
+26,227
| +33% | +$197K | ﹤0.01% | 2432 |
|
|
2025
Q1 | $608K | Sell |
80,353
-11,439
| -12% | -$86.6K | ﹤0.01% | 2456 |
|
|
2024
Q4 | $1.12M | Buy |
91,792
+20,881
| +29% | +$254K | ﹤0.01% | 2318 |
|
|
2024
Q3 | $1.19M | Buy |
70,911
+2,377
| +3% | +$39.8K | ﹤0.01% | 2310 |
|
|
2024
Q2 | $1.2M | Buy |
+68,534
| New | +$1.2M | ﹤0.01% | 2283 |
|